KeasClinical Studies ApS — Credit Rating and Financial Key Figures

KeasClinical Studies ApS (CVR number: 40794492) is a company from AARHUS. The company recorded a gross profit of -0.7 kDKK in 2024. The operating profit was -0.7 kDKK, while net earnings were -0.6 kDKK. The profitability of the company measured by Return on Assets (ROA) was -0.5 %, which can be considered poor and Return on Equity (ROE) was -0.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 76.2 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. KeasClinical Studies ApS's liquidity measured by quick ratio was 4.2 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.